These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4747062)

  • 21. Mutation of E1 glycoprotein of classical swine fever virus affects viral virulence in swine.
    Risatti GR; Holinka LG; Lu Z; Kutish GF; Tulman ER; French RA; Sur JH; Rock DL; Borca MV
    Virology; 2005 Dec; 343(1):116-27. PubMed ID: 16168455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
    Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
    Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparative study of vaccines obtained from lapinized strains of swine plague virus].
    Ageeva LS
    Veterinariia; 1967 Feb; 44(2):42-4. PubMed ID: 5629656
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies of the properties of cold induced classical swine fever virus mutants. Application to vaccination].
    Aynaud JM; Lejolly JC; Bibard C; Galicher C
    Bull Off Int Epizoot; 1971; 75(9):654-9. PubMed ID: 5170509
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of lyophilised C-strain vaccine after oral immunisation of domestic pigs and wild boar against classical swine fever: first results.
    Faust A; Lange E; Kaden V
    Dtsch Tierarztl Wochenschr; 2007 Nov; 114(11):412-7. PubMed ID: 18077931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Considerations on the possible application of marker vaccines against swine fever in European Union].
    Blaha T
    Tierarztl Prax; 1995 Dec; 23(6):580-1. PubMed ID: 8585076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candidate multi-peptide-vaccine against classical swine fever virus induced potent immunity with serological marker.
    Dong XN; Chen Y; Wu Y; Chen YH
    Vaccine; 2005 May; 23(28):3630-3. PubMed ID: 15882522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of modified live swine fever virus, prepared on tissue culture, for vaccination].
    Drazan J; Jerabek J; Hrabak R; Dubansky V
    Bull Off Int Epizoot; 1971; 75(9):675-81. PubMed ID: 5154371
    [No Abstract]   [Full Text] [Related]  

  • 29. A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge.
    Li N; Qiu HJ; Zhao JJ; Li Y; Wang MJ; Lu BW; Han CG; Hou Q; Wang ZH; Gao H; Peng WP; Li GX; Zhu QH; Tong GZ
    Vaccine; 2007 Apr; 25(15):2907-12. PubMed ID: 17007970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs.
    Dewulf J; Laevens H; Koenen F; Mintiens K; de Kruif A
    Prev Vet Med; 2004 Oct; 65(3-4):121-33. PubMed ID: 15488266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a multiplex real-time RT-PCR for quantitative and differential detection of wild-type viruses and C-strain vaccine of Classical swine fever virus.
    Zhao JJ; Cheng D; Li N; Sun Y; Shi Z; Zhu QH; Tu C; Tong GZ; Qiu HJ
    Vet Microbiol; 2008 Jan; 126(1-3):1-10. PubMed ID: 17658704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spying the neutralizing epitopes on E2 N-terminal by candidate epitope-vaccines against classical swine fever virus.
    Dong XN; Chen YH
    Vaccine; 2006 May; 24(19):4029-34. PubMed ID: 16504346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of crystal-violet glycerol hog cholera vaccine: comments on a proposed reproducible test.
    Ale CN; Songer JR
    Am J Vet Res; 1966 Nov; 27(121):1657-62. PubMed ID: 6008313
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental studies of the live-virus hog-cholera vaccine, "Suiferin," with special emphasis on the question of virus excretion by experimentally infected vaccinated animals].
    Liebke H; Korn G; Matthaeus W
    Zentralbl Veterinarmed B; 1971 Feb; 18(1):44-60. PubMed ID: 4932941
    [No Abstract]   [Full Text] [Related]  

  • 35. Porcine interleukin-3 enhances DNA vaccination against classical swine fever.
    Andrew M; Morris K; Coupar B; Sproat K; Oke P; Bruce M; Broadway M; Morrissy C; Strom D
    Vaccine; 2006 Apr; 24(16):3241-7. PubMed ID: 16457910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral immunization of pigs against classical swine fever. Course of the disease and virus transmission after simultaneous vaccination and infection.
    Kaden V; Schurig U; Steyer H
    Acta Virol; 2001 Feb; 45(1):23-9. PubMed ID: 11394574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of safety and protective value of a cell culture modified strain "C" vaccine of hog cholera/classical swine fever virus.
    Dahle J; Liess B
    Berl Munch Tierarztl Wochenschr; 1995 Jan; 108(1):20-5. PubMed ID: 7779071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral immunisation of wild boar against classical swine fever: concluding analysis of the recent field trials in Germany.
    Kaden V; Heyne H; Kiupel H; Letz W; Kern B; Lemmer U; Gossger K; Rothe A; Böhme H; Tyrpe P
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):179-85. PubMed ID: 12058591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of avirulent drug viral vaccine against hog cholera].
    But'ianov DD; Kos'ko FA
    Veterinariia; 1970 May; 5():71-2. PubMed ID: 5430621
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of the effectiveness of live viral vaccine against strain K hog cholera].
    Kovalenko IaR; Sidorov MA
    Veterinariia; 1972 Jun; 48(6):54-5. PubMed ID: 5081403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.